Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011–2016)

References

• Griess P. Über die Einwirkung des Cyans auf Anthranilsäure. Eur J Inorg Chem. 1869;2:415–418.
   Google Scholar
• Selvam TP, Kumar PV. Quinazoline marketed drugs. Res Pharm. 2015;1:1–21.
   Google Scholar
• Connolly DJ, Cusack D, O’Sullivan TP, et al. Synthesis of quinazolinones and quinazolines. Tetrahedron. 2005;61:10153–10202.
   Web of Science ®Google Scholar
• Abida PN, Arpanarana M. An updated review: newer quinazoline derivatives under clinical trial. Int J Pharm Biol Sci Arch. 2011;2:1651–1657.
   Google Scholar
• Mhaske SB, Argade NP. The chemistry of recently isolated naturally occurring quinazolinone alkaloids. Tetrahedron. 2006;62:9787–9826.
   Web of Science ®Google Scholar
• Witt A, Bergman J. Recent developments in the field of quinazoline chemistry. Curr Org Chem. 2003;7:659–677.
   Web of Science ®Google Scholar
• Berest GG, Voskoboynik OY, Kovalenko SI, et al. Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1, 2, 4] triazino [2, 3-c] quinazoline-6-yl) thio] acetamides. Eur J Med Chem. 2011;46:6066–6074.
   PubMed Web of Science ®Google Scholar
• Hu J, Zhang Y, Dong L, et al. Design, synthesis, and biological evaluation of novel quinazoline derivatives as anti-inflammatory agents against lipopolysaccharide-induced acute lung injury in rats. Chem Biol Drug Des. 2015;85:672–684.
   PubMed Web of Science ®Google Scholar
• Ammerdorffer A, Stojanov M, Greub G, et al. Chlamydia trachomatis and chlamydia-like bacteria: new enemies of human pregnancies. Curr Opin Infect Dis. 2017;30:289–296.
   PubMed Web of Science ®Google Scholar
• Gillet D, Barbier J, Cintrat JC, et al. Quinazolinone derivatives for use in the treatment of chlamydiales infections patent. EP 3085374. 2016.
   Google Scholar
• Mitchell G, Mulholland NP, Bhonoah Y. Herbicidal compounds patent. WO 2016198585. 2016.
   Google Scholar
• Halby L, Arimondo P, Mai A, et al. Substituted quinazoline derivatives as dna methyltransferase inhibitors patent. WO 2016151144. 2016.
   Google Scholar
• Jansa P, Simon PLansdon E, et al. Quinazoline derivatives used to treat hiv patent. EP3237398 A1. 2017.
   Google Scholar
• Shen W, Xiao W, Maung J, et al. Quinazoline-7-ether compounds and methods of use patent. US 20140221406. 2014.
   Google Scholar
• Zhang D. Quinazoline derivatives as kinases inhibitors and methods of use thereof patent. US 2014235658. 2014.
   Google Scholar
• Hartz RA, Ahuja VT, Macor JE, et al. Quinazoline-based kinase inhibitors patent. WO 2016053794. 2017.
   Google Scholar
• Evarts J, Kaplan J, Kim M, et al. Phosphatidylinositol 3-kinase inhibitors patent. WO 2015200352. 2015.
   Google Scholar
• Kuo MY, Liao CB, Peng SZ, et al. Quinazoline compounds, method for preparing the same and use thereof patent. US 20150158854. 2015.
   Google Scholar
• Zhang Z. Quinazoline derivatives as tam family kinase inhibitors patent. WO 2015077375. 2015.
   Google Scholar
• Blum A. Sulfoximine substituted quinazolines for pharmaceutical compositions patent. WO 2015169677. 2015.
   Google Scholar
• Kley J, Blum A, Gottschling D, et al. Sulfoximine substituted quinazolines for pharmaceutical compositions patent. US 20170174668. 2017.
   Google Scholar
• Blum A, Gottschling D, Heckel A, et al. Sulfoximine substituted quinazolines and their use as mnk1 and/or mnk2 kinase inhibitors patent. WO 2014206922. 2014.
   Google Scholar
• Baska F, Kéri G, Őrfi L, et al. Styryl quinazoline derivatives as pharmaceutically active agents patent. WO 2015019121. 2015.
   Google Scholar
• Qian X, Zhu YL. Certain chemical entities, compositions, and methods patent. WO 2014047648. 2014.
   Google Scholar
• Wu Y, Niu C, Zou D, et al. Bis-quinazoline derivatives as inhibitors for epidermal growth factor receptor (EGFR) tyrosine kinase patent. US 20130296348. 2013.
   Google Scholar
• Leblond B, Casagrande AS, Desire L, et al. Dyrk1 inhibitors and uses thereof patent. WO 2013026806. 2013.
   Google Scholar
• Huang JJ, Liao CB, Chen PN. Quinazoline compounds as kinase inhibitors patent. US 20130165458. 2013.
   Google Scholar
• Bury MJ, Casillas LN, Charnley AK, et al. Amino quinazolines as kinase inhibitors patent. WO 2013025958. 2013.
   Google Scholar
• Chilin A, Marzaro G, Guiotto A, et al. Biphenyl tricyclic quinazoline compounds patent. WO 2012127012. 2012.
   Google Scholar
• Casuscelli F, Piutti C, Ermoli A, et al. Substituted pyrazolo-quinazoline derivatives as kinase inhibitors patent. WO 2012080990. 2012.
   Google Scholar
• Russu WA, Shallal HM. Piperazinylpyrimidine analogues as protein kinase inhibitors patent. WO 2012027495. 2012.
   Google Scholar
• Abbott D, Tigno-Aranjuez J. Compositions and methods for treating inflammatory disorders patent. WO 2011112588. 2011.
   Google Scholar
• Chung D, Schroeder CE, Sotsky J, et al. ML336: development of quinazolinone-based inhibitors against Venezuelan equine encephalitis virus (VEEV). 2013.
   Google Scholar
• Heil ML, Cosford NDP, Ardecky R, et al. Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections patent. US 20140256753. 2014.
   Google Scholar
• Mhaske SB, Lande JR. Pyrroloquinoline alkaloids as antimalarial agents and process for the preparation thereof patent. US 20150336947. 2015.
   Google Scholar
• Huggins PJ, Parsons JG. Quinazolinone compounds patent. US 20120040980. 2012.
   Google Scholar
• Taniguchi Y. The bromodomain and extra-terminal domain (BET) family: functional anatomy of BET paralogous proteins. Int J Mol Sci. 2016;17:1849.
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains. Nature. 2010;468:1067–1073.
   PubMed Web of Science ®Google Scholar
• Mertz JA, Conery AR, Bryant BM, et al. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci. 2011;108:16669–16674.
   PubMed Web of Science ®Google Scholar
• McLure KG, Young PR. Treatment of diseases by epigenetic regulation patent. US 20130281399. 2013.
   Google Scholar
• Kalkman HO. Use of 1H-quinazoline-2,4-diones patent. US 20130096145. 2013.
   Google Scholar
• Scott WJ, Möwes M, Liu N, et al. Alkoxy-substituted 2, 3-dihydroimidazo [1, 2-c] quinazolines patent. US 20130330327. 2011.
   Google Scholar
• Brahimi F, Rachid Z, Qiu Q, et al. Multiple mechanisms of action of ZR2002 in human breast cancer cells: a novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA. Int J Cancer. 2004;112:484–491.
   PubMed Web of Science ®Google Scholar
• Novel quinazoline nitrogen mustard compound, and preparation method and application thereof to treatment of cancer patent. CN103193722 A. 2013.
   Google Scholar
• Jean-Claude B. Imidazotetrazinone-based combi-molecules patent. US20120283280. 2012.
   Google Scholar
• Kshirsagar U. Recent developments in the chemistry of quinazolinone alkaloids. Org Biomol Chem. 2015;13:9336–9352. Recent developments in the chemistry of quinazolinone alkaloids
   PubMed Web of Science ®Google Scholar